InnoCare Pharma Limited

InnoCare Pharma Limitedverified

INCPF

Price:

$2.13

Market Cap:

$19.47B

InnoCare Pharma Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases. It develops Orelabrutinib, an BTK inhibitor to treat patients with relapsed and/or refractory (r/r) chronic lymphocytic leukemia, r/r mantle cell lymphoma, r/r Waldenstrom's macroglobulinemia, r/r marginal zone lymphoma, r/r diffuse large B-cell lymphoma (DLBCL)- MCD, r/r central nervous system lymphoma, combo w/MIL-62, systemic lupus erythematosus, immune thrombocytopenia purpura, multiple sclerosis, and neuromyelitis optica spectrum disorder. The company is also developing ICP-192, a pan-FGFR inhibitor that is in a Phase I/...[Read more]

Industry

Biotechnology

IPO Date

2021-07-09

Stock Exchange

OTC

Ticker

INCPF

The ROE as of December 2025 (TTM) for InnoCare Pharma Limited (INCPF) is -3.10%

According to InnoCare Pharma Limited’s latest financial reports and current stock price. The company's current ROE is -3.10%. This represents a change of 298.74% compared to the average of -0.78% of the last 4 quarters.

InnoCare Pharma Limited (INCPF) Historical ROE (quarterly & annually)

How has INCPF ROE performed in the past?

The mean historical ROE of InnoCare Pharma Limited over the last ten years is 22.29%. The current -3.10% ROE has changed -113.89% with respect to the historical average. Over the past ten years (40 quarters), INCPF's ROE was at its highest in in the December 2019 quarter at 49.56%. The ROE was at its lowest in in the June 2022 quarter at -5.91%.

Quarterly (TTM)
Annual

Average

22.29%

Median

-3.85%

Minimum

-12.61%

Maximum

87.16%

InnoCare Pharma Limited (INCPF) ROE by Quarter and Year

Discovering the peaks and valleys of InnoCare Pharma Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 913.34%

Maximum Annual ROE = 87.16%

Minimum Annual Increase = -117.72%

Minimum Annual ROE = -12.61%

Quarterly (TTM)
Annual
YearROEChange
2024-6.55%-25.81%
2023-8.83%-24.32%
2022-11.67%913.34%
2021-1.15%-90.87%
2020-12.61%-117.72%
201971.17%17.03%
201860.81%-30.23%

InnoCare Pharma Limited (INCPF) Average ROE

How has INCPF ROE performed in the past?

The current ROE of InnoCare Pharma Limited (INCPF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

-9.02%

5-year avg

-8.16%

10-year avg

22.29%

InnoCare Pharma Limited (INCPF) ROE vs. Peers

How is INCPF’s ROE compared to its peers?

InnoCare Pharma Limited’s ROE is greater than Shanghai Junshi Biosciences Co., Ltd. (-15.79%), less than Genscript Biotech Corporation (71.23%), less than ALK-Abelló A/S (18.18%), less than Laboratorios Farmaceuticos Rovi, S.A. (23.26%), less than Zealand Pharma A/S (64.52%), less than Camurus AB (publ) (21.18%), less than COSMOS Pharmaceutical Corporation (12.55%), less than Fielmann AG (18.07%), less than Clicks Group Limited (47.34%), less than Gedeon Richter PLC (17.11%),

Build a custom stock screener for InnoCare Pharma Limited (INCPF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InnoCare Pharma Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

InnoCare Pharma Limited (INCPF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like InnoCare Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is InnoCare Pharma Limited's ROE?

How is the ROE calculated for InnoCare Pharma Limited (INCPF)?

What is the highest ROE for InnoCare Pharma Limited (INCPF)?

What is the 3-year average ROE for InnoCare Pharma Limited (INCPF)?

What is the 5-year average ROE for InnoCare Pharma Limited (INCPF)?

How does the current ROE for InnoCare Pharma Limited (INCPF) compare to its historical average?